HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 286/4/R634    most recent 00464.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by McDougall, J. J. Articles by McDougall, C. M. Search for Related Content PubMed PubMed Citation Articles by McDougall, J. J. Articles by McDougall, C. M.

INFLAMMATION, CYTOKINES, AND TEMPERATURE REGULATION

Loss of vasomotor responsiveness to the µ-opioid receptor ligand endomorphin-1 in adjuvant monoarthritic rat knee joints

McCaig Centre for Joint Injury and Arthritis Research, Department of Physiology and Biophysics, University of Calgary, Calgary, Alberta, Canada T2N 4N1

Submitted 15 August 2003 ; accepted in final form 5 December 2003

Endomorphin-1 is a short-chain neuropeptide with a high affinity for the µ-opioid receptor and has recently been localized in acutely inflamed knee joints where it was found to reduce inflammation. The present study examined the propensity of endomorphin-1 to modulate synovial blood flow in normal and adjuvant-inflamed rat knee joints. Under deep urethane anesthesia, endomorphin-1 was topically applied to exposed normal and 1 wk adjuvant monoarthritic knee joints (0.1 ml bolus; 10^-12-10^-9 mol). Relative changes in articular blood flow were measured by laser Doppler perfusion imaging and vascular resistances in response to the opioid were calculated. In normal knees, endomorphin-1 caused a dose-dependent increase in synovial vascular resistance and this effect was significantly inhibited by the specific µ-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr amide (CTOP) (P < 0.0001, 2-factor ANOVA, n = 5-7). One week after adjuvant inflammation, the hypoaemic effect of endormophin-1 was completely abolished (P < 0.0001, 2-factor ANOVA, n = 5-7). Immunohistochemical analysis of normal and adjuvant-inflamed joints showed a ninefold increase in endomorphin-1 levels in the monoarthritic knee compared with normal control. Western blotting and immunohistochemistry revealed a moderate number of µ-opioid receptors in normal knees; however, µ-opioid receptors were almost undetectable in arthritic joints. These findings demonstrate that peripheral administration of endomorphin-1 reduces knee joint blood flow and this effect is not sustainable during advanced inflammation. The loss of this hypoaemic response appears to be due to downregulation of µ-opioid receptors as a consequence of endomorphin-1 accumulation within the arthritic joint.

arthritis; blood flow; opioids; neuropeptides; inflammation